These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 11807180)

  • 1. Structure, function, and inhibition of chemokines.
    Fernandez EJ; Lolis E
    Annu Rev Pharmacol Toxicol; 2002; 42():469-99. PubMed ID: 11807180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine: receptor structure, interactions, and antagonism.
    Allen SJ; Crown SE; Handel TM
    Annu Rev Immunol; 2007; 25():787-820. PubMed ID: 17291188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonistic and antagonistic activities of chemokines.
    Loetscher P; Clark-Lewis I
    J Leukoc Biol; 2001 Jun; 69(6):881-4. PubMed ID: 11404371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
    Onuffer JJ; Horuk R
    Trends Pharmacol Sci; 2002 Oct; 23(10):459-67. PubMed ID: 12368070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the structural mechanisms for biological activity of the chemokine family.
    Baysal C; Atilgan AR
    Proteins; 2001 May; 43(2):150-60. PubMed ID: 11276085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutics that modulate chemokine networks.
    Schwarz MK; Wells TN
    Nat Rev Drug Discov; 2002 May; 1(5):347-58. PubMed ID: 12120410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why chemokines are cytokines while their receptors are not cytokine ones?
    Goncharova LB; Tarakanov AO
    Curr Med Chem; 2008; 15(13):1297-304. PubMed ID: 18537609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemokines and chemokine receptors. Review article].
    Niederlová J; Koubek K
    Sb Lek; 1999; 100(3):169-89. PubMed ID: 11221465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in chemokines and chemokine receptors.
    Zlotnik A; Morales J; Hedrick JA
    Crit Rev Immunol; 1999; 19(1):1-47. PubMed ID: 9987599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines: roles in leukocyte development, trafficking, and effector function.
    Ono SJ; Nakamura T; Miyazaki D; Ohbayashi M; Dawson M; Toda M
    J Allergy Clin Immunol; 2003 Jun; 111(6):1185-99; quiz 1200. PubMed ID: 12789214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A burgeoning family of biological mediators: chemokines and chemokine receptors.
    Le Y; Gong W; Shen W; Li B; Dunlop NM; Wang JM
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):143-50. PubMed ID: 10912618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemokines--perspectives for using agents that block their action in therapy].
    Waśniowska K
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():37-46. PubMed ID: 15069373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines.
    Reckless J; Grainger DJ
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):803-11. PubMed ID: 10359667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
    Lau EK; Allen S; Hsu AR; Handel TM
    Adv Protein Chem; 2004; 68():351-91. PubMed ID: 15500866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines and brain functions.
    Banisadr G; Rostène W; Kitabgi P; Parsadaniantz SM
    Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):387-99. PubMed ID: 16101548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines.
    Laing KJ; Secombes CJ
    Dev Comp Immunol; 2004 May; 28(5):443-60. PubMed ID: 15062643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors.
    Szpakowska M; Fievez V; Arumugan K; van Nuland N; Schmit JC; Chevigné A
    Biochem Pharmacol; 2012 Nov; 84(10):1366-80. PubMed ID: 22935450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine family. Potential therapeutic targets from allergy to HIV infection.
    Proudfoot AE
    Eur J Dermatol; 1998; 8(3):147-57. PubMed ID: 9649701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation of unfavorable sequence motifs that contribute to the chemokine quaternary state.
    Kagiampakis I; Jin H; Kim S; Vannucci M; LiWang PJ; Tsai J
    Biochemistry; 2008 Oct; 47(40):10637-48. PubMed ID: 18781776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.